Tag

Phase I

COVID-19

/ /
CR2O sponsors a Phase I SARS-CoV-2 monoclonal antibody clinical trial, funded by Horizon2020.

Influenza

/ / / /
CR2O is part of a consortium that investigates next generation broad spectrum influenza vaccines through Phase I and Controlled Human Infection Model (CHIM). Funding from Horizon2020.